The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Someone's got faith in IHC, 350k shares bought at 67.75p (£237.1k buy) Wish I had that sort of cash!
350k buy at 67.75p (£237K) Interesting...
I can't believe there are still some people selling at 66p into the rise. This is a great investment with virtually no risk as I see it. Small, profitable growth company selling medical equipment during pandemic crisis! Hopefully maiden dividend next year.
All it will take is some good media coverage and this will move permanently into the 70ps IMO
Good update again today and lets hope its followed by further updates as the remaining £2m ventilator contract for the NHS is filled.
yes nice positive update.
https://uk.advfn.com/stock-market/london/inspiration-healthcare-IHC/share-news/Inspiration-Healthcare-Group-PLC-Update-on-Ventila/83105733
Very good news all round:
- strong trading continues into H2
- the original NHS order deliveries will further benefit H2
- the second NHS order via the newly acquired SLE is a further bonus I was unaware of?
- further optimism as to the outlook and to acquisition integration
Hello troutisout, had missed the Clinical Services Journal article. Very interesting as the present largely forced air warming must be an unneeded worry worldwide for both Operating Theatre & ICU personnel with the covid bug around.
.....and I suppose even more so, now delayed elective surgeries and the reported 10m backlog, now need to be worked through.
IHC, retweeting this post from 3 months ago, looks like demand is still soaring.
https://www.clinicalservicesjournal.com/story/32782/demand-for-air-free-patient-warming-technology-soars-in-response-to-covid-19
This was in the Genedrive placing RNS, note the projected revenues for this test.
"Antibiotic-Induced Hearing Loss ("AIHL")
Around one in 500 infants carry a genetic mutation that's puts them at risk of suffering lifelong profound hearing loss after exposure to gentamycin, a commonly used antibiotic. genedrive has developed world's first rapid point-of-care genetic test for neonatal intensive care. There are no other point-of-care tests commercially available for AIHL and the Directors believe genedrive's test could support a new standard of care for all urgent case infants.
genedrive's AIHL test has a high clinical accuracy with 100% sensitivity and 100% specificity. Implementation trials for the test are progressing at Manchester and Liverpool but, as announced on 25 March 2020, have not been able to continue at the same pace as previous months as a result of NHS resources being diverted to address COVID-19.
On 24 April 2020, genedrive announced that it had entered into a distribution agreement with Inspiration Healthcare Group plc for the distribution of genedrive's AIHL test in the UK and Ireland. The Directors estimate the UK and global markets for this test to be worth up to £3.5 million and £35 million per year, respectively, to genedrive based on a price of £2,000 per Genedrive® unit and £35 per test."
Safy, I couldn't find it but I am sure there was an interview where it was mentioned that IHC would work towards getting a recommendation from NICE to use the test as gold standard, this would be done in line with the studies ongoing at the moment. I can only think that Genedrive are using IHC as they do have a good network of contacts/distributors that they already sell equipment to, the acquisition of SLE adds even more Global spread, so after the UK and Ireland, the rest of the World beckons....
Cheers Trout
What i can tell you is that its the first test of its kind in the world and within minutes can save a baby's hearing. Its been tested already etc.
Would you regard the IHC network to get sales as significant and to the best of your knowledge do they deliver big numbers?
I have always took it as IHC would distribute the test to UK and Ireland. They would both market the product at launch and IHC's contacts would be able to help this test become the 'Gold Standard' and I also remember seeing something about IHC would work towards NICE guidance to use the product. Obviously there was mention of further distribution through IHC's International network and this has just got much bigger with the SLE acquisition. This from a month ago from Genedrive,
"
Despite some initial concerns around the impact of lockdown on the Antibiotic Induced Hearing Loss (AIHL) project, the NHS evaluation programme has continued to run during the past few months. After a slow period, the programme pace has increased somewhat as lock-down measures have eased and the Company remains optimistic of completing the project and achieving the Autumn 2020 timeframe for commercial launch with Inspiration Healthcare Plc."
Hello gents,
Just wondering whether you folks have any insights on how IHC operates and how the partnership with GDR works?
Is it a case of IHC manage the sales or is the role of IHC to allow partners to trial it etc and leave sales to GDR?
https://www.proactiveinvestors.co.uk/companies/news/918037/genedrive-and-inspiration-healthcare-to-distribute-neonatal-hearing-loss-test-in-uk--ireland-918037.html
Interview with CEO here, all sounding very positive, the 30% rise was LFL and doesn't include the NHS ventilator contracts of which £2m have been delivered in H1 with £3m to follow.
https://t.co/9P2uGnB7Me?amp=1
I hope you got a few more, as it looks like others are after them now.
I think the ambiguity of the statements and lack of understanding of what market expectations are led to a panic sell off yesterday, now the dust has settled I see more investors buying in to the IHC story.
How do IHC manage to write an RNS with 30% increase in sales in H1, but share price falls in early trading? Its because they wrote...
1) Only 40% ventillators sourced (although this was a one off order not expected before CV19, therefore a bonus!)
2) Increase in sales H1 biased.
These guys need to milk the positive news and gloss over the items which some investors (traders) will take to be negative news.
Last time the RNS was issued twice as the same thing happened.
Please BOD, get someone better to write your RNS results / trade updates - frustrating that we can't break 70p+
“the Group has continued to enjoy a very strong start to the year with underlying revenues in the first six months of the financial year circa 30 per cent ahead of those achieved in the same period last year.”
Great. Especially when complemented with a profitable acquisition to help further increase margins. Interesting to see when the share price reflects the current success.
Encouraging trading update today - confident in at least achieving expectations, and with a healthy order book in the core business augmented by COVID-19 opportunities.
In particular, the acquisition of SLE is going well, and the language remains bullish with talk of short and medium-term earnings enhancement:
Https://uk.advfn.com/stock-market/london/inspiration-healthcare-IHC/share-news/Inspiration-Healthcare-Group-PLC-Trading-Update/83042079
picked up a few more, this is undervalued considering the recent acquisition.
I think IHC have the perfect plan for growth without compromising business health. And yes, that's a capital idea to email him!
It's not the results that are expected, but a trading statement post H1.
The figures will be interesting as they have said there were good sales prior to and during the C19 outbreak. Not heard anymore about the last NHS ventilators to be delivered, so looks like the £5.25m sales figure will be split between H1 and H2.
Going forward looking very positive and well worth building on any investment here.
There will be huge demand for all healthcare equipment in my view. CV19 has made people realise the value of the NHS and they will be more happy to pay more taxes to fund better services in future. With neo-natal care, healthcare providers will spend whatever is needed to look after premature babies; no will argue that this spending is discretionary.
IHC just needs some good media coverage and someone like Simon Thompson at Investors Chronicle to champion. I might drop him an email, flagging up that results are due in the next week.
I have also been tempted to add more here. Volume is low, but this company is doing all the right things. It's clear in its long term aims to grow revenues to greater than £100mn through targeted acquisitions.
The only negative I can stretch to lies in their long term aim to be the leader in specifically neonatal care, with most health plays being based around the growing ageing population narrative. They say they expect an increasing number of births (such as premature) requiring their services and products, but, even if this is not true, as the world gets wealthier most likely more resources per birth will be mobilised anyway, thus still creating compelling growing demand for IHC.
The trade update is due next week (probably Thursday 13/8 if similar day to last year). I can't believe it will be anything other than good and should be one of the few companies to benefit from CV19 (ventillators and other supplies for NHS) Despite positive news from IHC and recent takeover of another profitable company (with oversubscribed fund raise at 65p), the share price is still langushing. For whatever reason this company seems to get very little media coverage, so daily volume is low. I've just added to my holding at crazy low price of 62.15p. Can't believe there isn't at least 25% upside here in a week. NB this isn't a CV19 all or nothing share, but a solid investment in a growing company that intends to pay a dividend next year and is already profitable. Good luck all holders.
Let’s hope their communications get better as this will rocket on the next rns Come on BOD get the great news out tgere